CD4 and influenza: The current Trivalent Influenza Vaccine (TIV) is poor at eliciting CD4+ T-cell6–15 or CD8+ T-cell11,16 responses after vaccination, and much recent focus has been on finding an association between T-cell responses and influenza specific antibody responses17–20.